Health

CVS Selling EpiPen's Competitor Product at One Sixth of the Current Price

0 920

In September of 2016 the medical community, and the United States congress, were appalled when healthcare company Mylan Inc. announced a 500% price increase (now currently at a cost of $608 dollars) for a two-pack of allergy attack saving EpiPens. The free market once again comes to the rescue as CVS has just announced it is selling a generic version of the drug at a sixth of the price.

Continue Reading

Recommended Reading


The free market is a truly awe-inspiring complex of relationships in which the rational self-interest of individuals unites all industries, all markets, all occupations, all production, and all consumption into a harmonious, progressing system serving the well-being of all who participate in it.

- George Reisman